voltage-dependent ca2 channels Search Results


93
Alomone Labs anti α2δ 1 antibody
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Anti α2δ 1 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/Anti-CACNA2D1+(CaV%CE%B12%CE%B41)+(extracellular)+Antibody/10__1097_slash_aln__0000000000002648-59-7-11
Average 93 stars, based on 1 article reviews
anti α2δ 1 antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Brehm GmbH ciliary voltage-dependent ca2+-channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Ciliary Voltage Dependent Ca2+ Channels, supplied by Brehm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/ciliary+voltage+dependent+ca2++channels/pm26487631-1015-14-18
Average 90 stars, based on 1 article reviews
ciliary voltage-dependent ca2+-channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Balzer GmbH voltage-dependent ca 2+ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca 2+ Channels, supplied by Balzer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca+2++channels/pmc06724767-662-24-14
Average 90 stars, based on 1 article reviews
voltage-dependent ca 2+ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Kitayama Labes Co Ltd voltage-dependent p/q-type ca2 channel
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent P/Q Type Ca2 Channel, supplied by Kitayama Labes Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+p+q+type+ca2+channel/pm23125310-226-11-4
Average 90 stars, based on 1 article reviews
voltage-dependent p/q-type ca2 channel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Trudeau Institute Inc voltage-dependent ca 2+ channels (vdccs)
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca 2+ Channels (Vdccs), supplied by Trudeau Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca+2++channels++vdccs+/pmc01573621-160-45-72
Average 90 stars, based on 1 article reviews
voltage-dependent ca 2+ channels (vdccs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Heumann Pharma voltage-dependent l-type ca2+ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent L Type Ca2+ Channels, supplied by Heumann Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+l+type+ca2++channels/10__1113_slash_ep087426-65-6-19
Average 90 stars, based on 1 article reviews
voltage-dependent l-type ca2+ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Hirschmann voltage-dependent ca2+ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca2+ Channels, supplied by Hirschmann, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca2++channels/10__1152_slash_ajplung__1995__268__4__l642-17-3-20
Average 90 stars, based on 1 article reviews
voltage-dependent ca2+ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bostel LLC voltage-dependent na+ or ca2+ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Na+ Or Ca2+ Channels, supplied by Bostel LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+na++or+ca2++channels/pm15515014-133-19-24
Average 90 stars, based on 1 article reviews
voltage-dependent na+ or ca2+ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Putney Inc voltage dependent ca2+ channels (vocs)
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca2+ Channels (Vocs), supplied by Putney Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca2++channels++vocs+/pm22137608-182-3-14
Average 90 stars, based on 1 article reviews
voltage dependent ca2+ channels (vocs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Meves Pharmaceuticals voltage-dependent na+ or ca2+ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Na+ Or Ca2+ Channels, supplied by Meves Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+na++or+ca2++channels/pm15515014-133-20-28
Average 90 stars, based on 1 article reviews
voltage-dependent na+ or ca2+ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Chugai voltage-dependent ca 2÷ channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca 2÷ Channels, supplied by Chugai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca+2%C3%B7+channels/10__1007_slash_bf00114510-216-68-32
Average 90 stars, based on 1 article reviews
voltage-dependent ca 2÷ channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nicar Laboratories voltage-dependent ca2 channels
Fig. 1. Chronic morphine treatment increases <t>α2δ-1</t> association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.
Voltage Dependent Ca2 Channels, supplied by Nicar Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/voltage-dependent+ca2++channels/voltage+dependent+ca2+channels/pm15525683-224-10-16
Average 90 stars, based on 1 article reviews
voltage-dependent ca2 channels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Chronic morphine treatment increases α2δ-1 association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 1. Chronic morphine treatment increases α2δ-1 association with N-methyl-d-aspartate receptors at spinal cord synapses. (A, B) Representative blots and quantification of α2δ-1 protein levels in the dorsal root ganglion (DRG; A) and dorsal spinal cord (B) from vehi- cle-treated (V) and morphine-treated (M) rats (n = 6 rats in each group). (C) Coimmunoprecipitation (IP) analysis shows that GluN1 coprecipi- tated with α2δ-1 in the membrane extracts of dorsal spinal cord tissues of rats treated with vehicle or morphine for 8 days (n = 6 rats in each group). The amount of α2δ-1 proteins was normalized to that of GluN1 in the same sample, and the mean α2δ-1 level in vehicle-treated rats was considered to be 1. (D) Representative gel images and quantification of GluN1 and α2δ-1 protein amounts in dorsal spinal cord synaptosomes from vehicle- and morphine-treated rats (n = 6 rats in each group). (E) Coimmunoprecipitation analysis shows the effect of treatment with 1 µM α2δ-1Tat peptide and scrambled control (Cont) peptide on the α2δ-1–GluN1 complex level in spinal cord slices from morphine-treated rats (n = 6 rats in each group). Data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus the vehicle or control peptide group. IgG, immunoglobulin G; P(+), with α2δ-1Tat peptide; P(−), without α2δ-1Tat peptide.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Analysis, Membrane, Control, Co-Immunoprecipitation Assay

Fig. 2. α2δ-1 mediates chronic morphine exposure–induced potentiation of presynaptic N-methyl-d-aspartate receptor activity in the spinal dorsal horn. (A) Representative recording traces and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phos- phonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) of a lamina II neuron from a morphine-treated rat. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of mEPSCs of lamina II neurons (n = 11 neurons) from morphine-treated rats. (C) Representative recording traces and cumulative plots show that bath application of 50 μM AP5 had no effect on the frequency or amplitude of mEPSCs of a lamina II neuron pretreated with 100 µM gabapentin from a mor- phine-treated rat. (D) Summary data show no effect from 50 μM AP5 on the mean frequency or amplitude of mEPSCs of lamina II neurons (n = 10 neurons) pretreated with 100 µM gabapentin from morphine-treated rats. Data are shown as means ± SD. **P < 0.01 versus the baseline. ###P < 0.001 versus the baseline in the morphine + vehicle group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 2. α2δ-1 mediates chronic morphine exposure–induced potentiation of presynaptic N-methyl-d-aspartate receptor activity in the spinal dorsal horn. (A) Representative recording traces and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phos- phonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) of a lamina II neuron from a morphine-treated rat. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of mEPSCs of lamina II neurons (n = 11 neurons) from morphine-treated rats. (C) Representative recording traces and cumulative plots show that bath application of 50 μM AP5 had no effect on the frequency or amplitude of mEPSCs of a lamina II neuron pretreated with 100 µM gabapentin from a mor- phine-treated rat. (D) Summary data show no effect from 50 μM AP5 on the mean frequency or amplitude of mEPSCs of lamina II neurons (n = 10 neurons) pretreated with 100 µM gabapentin from morphine-treated rats. Data are shown as means ± SD. **P < 0.01 versus the baseline. ###P < 0.001 versus the baseline in the morphine + vehicle group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activity Assay, Patch Clamp

Fig. 3. α2δ-1 is involved in chronic morphine exposure–induced potentiation of N-methyl-d-aspartate receptor activity at primary afferent terminals in the spinal dorsal horn. (A, B) Representative recording traces show the effect of bath application of 50 μM 2-amino-5-phospho- nopentanoic acid (AP5) on evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a vehicle-incubated lamina II neuron from a morphine-treated rat. (C) Summary data show the effect of 50 μM AP5 on the amplitude (n = 10 neurons) and paired-pulse ratio (n = 10 neurons) of evoked monosynaptic excitatory postsynaptic currents of vehicle-incubated lamina II neurons in morphine-treated rats. (D, E) Representative recording traces show no effect from bath application of 50 μM AP5 on the amplitude of mono- synaptically evoked excitatory postsynaptic currents (D) or the paired-pulse ratio (E) of a lamina II neuron in spinal cord slices pretreated with 100 µM gabapentin in a morphine-treated rat. (F) Summary data show no effect from 50 μM AP5 on the mean amplitude (n = 11 neurons) or paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons pretreated with 100 µM gab- apentin from morphine-treated rats. The data are shown as means ± SD. *P < 0.05; ***P < 0.001 versus the baseline. ##P < 0.01 versus the baseline in the morphine + vehicle group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 3. α2δ-1 is involved in chronic morphine exposure–induced potentiation of N-methyl-d-aspartate receptor activity at primary afferent terminals in the spinal dorsal horn. (A, B) Representative recording traces show the effect of bath application of 50 μM 2-amino-5-phospho- nopentanoic acid (AP5) on evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a vehicle-incubated lamina II neuron from a morphine-treated rat. (C) Summary data show the effect of 50 μM AP5 on the amplitude (n = 10 neurons) and paired-pulse ratio (n = 10 neurons) of evoked monosynaptic excitatory postsynaptic currents of vehicle-incubated lamina II neurons in morphine-treated rats. (D, E) Representative recording traces show no effect from bath application of 50 μM AP5 on the amplitude of mono- synaptically evoked excitatory postsynaptic currents (D) or the paired-pulse ratio (E) of a lamina II neuron in spinal cord slices pretreated with 100 µM gabapentin in a morphine-treated rat. (F) Summary data show no effect from 50 μM AP5 on the mean amplitude (n = 11 neurons) or paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons pretreated with 100 µM gab- apentin from morphine-treated rats. The data are shown as means ± SD. *P < 0.05; ***P < 0.001 versus the baseline. ##P < 0.01 versus the baseline in the morphine + vehicle group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activity Assay, Transcranial Magnetic Stimulation, Incubation, Patch Clamp

Fig. 4. α2δ-1 is essential for the chronic morphine exposure–induced activation of presynaptic N-methyl-d-aspartate receptors in the spinal dorsal horn. (A) Representative recording trace and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phos- phonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) of a lamina II neuron from a morphine-treated wild-type (WT) mouse. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of mEPSCs (n = 11 neurons) in spinal cord slices from morphine-treated WT mice. (C) Representative recording traces and cumulative plots show no effect from AP5 on the frequency or amplitude of mEPSCs of a lamina II neuron from a morphine-treated α2δ-1 knockout (KO) mouse. (D) Summary data show no effect of AP5 on the mean frequency or amplitude of mEPSCs (n = 10 neurons) in spinal cord slices from morphine-treated α2δ-1 KO mice. The data are shown as means ± SD. ***P < 0.001 versus the baseline. ##P < 0.01 versus the baseline in the WT group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 4. α2δ-1 is essential for the chronic morphine exposure–induced activation of presynaptic N-methyl-d-aspartate receptors in the spinal dorsal horn. (A) Representative recording trace and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phos- phonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) of a lamina II neuron from a morphine-treated wild-type (WT) mouse. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of mEPSCs (n = 11 neurons) in spinal cord slices from morphine-treated WT mice. (C) Representative recording traces and cumulative plots show no effect from AP5 on the frequency or amplitude of mEPSCs of a lamina II neuron from a morphine-treated α2δ-1 knockout (KO) mouse. (D) Summary data show no effect of AP5 on the mean frequency or amplitude of mEPSCs (n = 10 neurons) in spinal cord slices from morphine-treated α2δ-1 KO mice. The data are shown as means ± SD. ***P < 0.001 versus the baseline. ##P < 0.01 versus the baseline in the WT group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activation Assay, Knock-Out, Patch Clamp

Fig. 5. α2δ-1 is required for the chronic morphine exposure–induced increase in N-methyl-d-aspartate receptor activity at primary affer- ent terminals. (A, B) Representative current traces show the effect of bath application of 50 μM 2-amino-5-phosphonopentanoic acid (AP5) on the amplitude of evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a lamina II neuron from a morphine-treated wild-type (WT) mouse. (C) Summary data show the effect of 50 μM AP5 on the mean amplitude (n = 11 neurons) and paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices of mor- phine-treated WT mice. (C, D) Representative current traces show no effect of AP5 on the mean amplitude of evoked monosynaptic excitatory postsynaptic currents (C) or paired-pulse ratio (D) of a lamina II neuron of a morphine-treated α2δ-1 knockout (KO) mouse. (E) Group data show the lack of effect of 50 μM AP5 on the amplitude (n = 11 neurons) and the paired-pulse ratio (n = 11 neurons) of monosynaptic excit- atory postsynaptic currents of lamina II neurons from spinal cord slices of morphine-treated α2δ-1 KO mice. The data are shown as means ± SD. **P < 0.05; **P < 0.01 versus the baseline. #P < 0.05 versus the baseline in the WT group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 5. α2δ-1 is required for the chronic morphine exposure–induced increase in N-methyl-d-aspartate receptor activity at primary affer- ent terminals. (A, B) Representative current traces show the effect of bath application of 50 μM 2-amino-5-phosphonopentanoic acid (AP5) on the amplitude of evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a lamina II neuron from a morphine-treated wild-type (WT) mouse. (C) Summary data show the effect of 50 μM AP5 on the mean amplitude (n = 11 neurons) and paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices of mor- phine-treated WT mice. (C, D) Representative current traces show no effect of AP5 on the mean amplitude of evoked monosynaptic excitatory postsynaptic currents (C) or paired-pulse ratio (D) of a lamina II neuron of a morphine-treated α2δ-1 knockout (KO) mouse. (E) Group data show the lack of effect of 50 μM AP5 on the amplitude (n = 11 neurons) and the paired-pulse ratio (n = 11 neurons) of monosynaptic excit- atory postsynaptic currents of lamina II neurons from spinal cord slices of morphine-treated α2δ-1 KO mice. The data are shown as means ± SD. **P < 0.05; **P < 0.01 versus the baseline. #P < 0.05 versus the baseline in the WT group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activity Assay, Transcranial Magnetic Stimulation, Knock-Out, Patch Clamp

Fig. 6. α2δ-1–Bound N-methyl-d-aspartate receptors mediate the chronic morphine exposure–induced increase in presynaptic N-methyl- d-aspartate receptor activity in the spinal cord. (A) Representative recording traces and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phosphonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents of a lamina II neuron pretreated with control peptide (1 µM) from a spinal cord slice of a morphine-treated rat. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs; n = 10 neurons) in spinal cord slices pretreated with control peptide from morphine-treated rats. (C) Representative recording traces and cumulative plots show no effect of AP5 on the frequency or amplitude of mEPSCs of a lamina II neuron pretreated with α2δ-1Tat peptide (1 µM) from a spinal cord slice of a morphine-treated rat. (D) Summary data show no effect of AP5 on the mean frequency or amplitude of mEPSCs (n = 11 neurons) in spinal cord slices pretreated with α2δ-1Tat peptide from morphine-treated rats. The data are shown as means ± SD. ***P < 0.001 versus the baseline. ###P < 0.001 versus the baseline in the morphine + control peptide group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 6. α2δ-1–Bound N-methyl-d-aspartate receptors mediate the chronic morphine exposure–induced increase in presynaptic N-methyl- d-aspartate receptor activity in the spinal cord. (A) Representative recording traces and cumulative plots show the effect of bath application of 50 μM 2-amino-5-phosphonopentanoic acid (AP5) on the frequency and amplitude of miniature excitatory postsynaptic currents of a lamina II neuron pretreated with control peptide (1 µM) from a spinal cord slice of a morphine-treated rat. (B) Summary data show the effect of 50 μM AP5 on the mean frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs; n = 10 neurons) in spinal cord slices pretreated with control peptide from morphine-treated rats. (C) Representative recording traces and cumulative plots show no effect of AP5 on the frequency or amplitude of mEPSCs of a lamina II neuron pretreated with α2δ-1Tat peptide (1 µM) from a spinal cord slice of a morphine-treated rat. (D) Summary data show no effect of AP5 on the mean frequency or amplitude of mEPSCs (n = 11 neurons) in spinal cord slices pretreated with α2δ-1Tat peptide from morphine-treated rats. The data are shown as means ± SD. ***P < 0.001 versus the baseline. ###P < 0.001 versus the baseline in the morphine + control peptide group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activity Assay, Control, Patch Clamp

Fig. 7. α2δ-1–Bound N-methyl-d-aspartate receptors are critically involved in chronic morphine exposure–induced activation of N-methyl- d-aspartate receptors at primary afferent terminals. (A, B) Representative current traces show the effect of bath application of 50 μM 2-ami- no-5-phosphonopentanoic acid (AP5) on the amplitude of evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a lamina II neuron from a spinal cord slice pretreated with control peptide (1 µM) from a morphine-treated rat. (C) Summary data show the effect of 50 μM AP5 on the mean amplitude (n = 11 neurons) and paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices pretreated with control peptide from morphine-treated rats. (D, E) Representative current traces show no effect of AP5 on the amplitude of evoked monosynaptic excitatory postsynaptic currents (D) or paired-pulse ratio (E) of a lamina II neuron from a spinal cord slice pretreated with α2δ-1Tat peptide (1 µM) from a morphine-treated rat. (F) Summary data show no effect of AP5 on the mean amplitude (n = 11 neurons) or paired-pulse ratio (n = 11 neurons) of evoked monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices pretreated with α2δ-1Tat peptide from morphine-treated rats. The data are shown as means ± SD. **P < 0.01; ***P < 0.001 versus the baseline. ###P < 0.001 versus the baseline in the morphine + control peptide group.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 7. α2δ-1–Bound N-methyl-d-aspartate receptors are critically involved in chronic morphine exposure–induced activation of N-methyl- d-aspartate receptors at primary afferent terminals. (A, B) Representative current traces show the effect of bath application of 50 μM 2-ami- no-5-phosphonopentanoic acid (AP5) on the amplitude of evoked monosynaptic excitatory postsynaptic currents (A) and the paired-pulse ratio (B) of a lamina II neuron from a spinal cord slice pretreated with control peptide (1 µM) from a morphine-treated rat. (C) Summary data show the effect of 50 μM AP5 on the mean amplitude (n = 11 neurons) and paired-pulse ratio (n = 11 neurons) of monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices pretreated with control peptide from morphine-treated rats. (D, E) Representative current traces show no effect of AP5 on the amplitude of evoked monosynaptic excitatory postsynaptic currents (D) or paired-pulse ratio (E) of a lamina II neuron from a spinal cord slice pretreated with α2δ-1Tat peptide (1 µM) from a morphine-treated rat. (F) Summary data show no effect of AP5 on the mean amplitude (n = 11 neurons) or paired-pulse ratio (n = 11 neurons) of evoked monosynaptic excitatory postsynaptic currents of lamina II neurons from spinal cord slices pretreated with α2δ-1Tat peptide from morphine-treated rats. The data are shown as means ± SD. **P < 0.01; ***P < 0.001 versus the baseline. ###P < 0.001 versus the baseline in the morphine + control peptide group.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Activation Assay, Transcranial Magnetic Stimulation, Control, Patch Clamp

Fig. 8. α2δ-1 at the spinal cord level mediates chronic morphine exposure–induced hyperalgesia and analgesic tolerance. (A, B) Time course of changes in the baseline mechanical (A) and thermal (B) withdrawal thresholds and the analgesic effect of morphine in rats treated with systemic morphine plus vehicle (n = 8 rats) or gabapentin (GBP, 100 mg/kg, n = 8 rats). (C, D) Time course of changes in the baseline mechanical (C) and thermal (D) withdrawal thresholds and the analgesic effect of morphine in rats treated with systemic morphine plus control (cont) peptide (1 μg) or α2δ-1Tat peptide (1 μg; n = 10 rats in each group). (E, F) Time course of changes in the baseline mechanical (E) and thermal (F) withdrawal thresholds and the analgesic effect of morphine in wild-type (WT) and α2δ-1 knockout (KO) mice (n = 8 mice/ group). The baseline withdrawal threshold was measured before each morphine injection, and the analgesic effect of morphine was tested 30 min after morphine injection. *P < 0.05; **P < 0.01; ***P < 0.001 versus values at day 1. The data are shown as means ± SD. #P < 0.05; ##P < 0.01; ###P < 0.001 versus values in the corresponding control group (vehicle, cont peptide, or WT) at the same time point.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 8. α2δ-1 at the spinal cord level mediates chronic morphine exposure–induced hyperalgesia and analgesic tolerance. (A, B) Time course of changes in the baseline mechanical (A) and thermal (B) withdrawal thresholds and the analgesic effect of morphine in rats treated with systemic morphine plus vehicle (n = 8 rats) or gabapentin (GBP, 100 mg/kg, n = 8 rats). (C, D) Time course of changes in the baseline mechanical (C) and thermal (D) withdrawal thresholds and the analgesic effect of morphine in rats treated with systemic morphine plus control (cont) peptide (1 μg) or α2δ-1Tat peptide (1 μg; n = 10 rats in each group). (E, F) Time course of changes in the baseline mechanical (E) and thermal (F) withdrawal thresholds and the analgesic effect of morphine in wild-type (WT) and α2δ-1 knockout (KO) mice (n = 8 mice/ group). The baseline withdrawal threshold was measured before each morphine injection, and the analgesic effect of morphine was tested 30 min after morphine injection. *P < 0.05; **P < 0.01; ***P < 0.001 versus values at day 1. The data are shown as means ± SD. #P < 0.05; ##P < 0.01; ###P < 0.001 versus values in the corresponding control group (vehicle, cont peptide, or WT) at the same time point.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Control, Knock-Out, Injection

Fig. 9. Treatment with gabapentin (GBP) or α2δ-1Tat peptide attenuates established hyperalgesia and analgesic tolerance induced by chronic morphine treatment. (A, B) Effect of intraperitoneal injection of vehicle or gabapentin (100 mg/kg) on the baseline mechanical (A) and heat (B) withdrawal thresholds and the acute analgesic effect of morphine (5 mg/kg, intraperitoneally) in rats pretreated with chronic morphine for 8 days (n = 8 rats in each groups). (C, D) Effect of intrathecal injection of α2δ-1Tat peptide (1 μg) or control (cont) peptide (1 μg) on the baseline mechanical (C) and heat (D) withdrawal thresholds and the acute analgesic effect of morphine (5 mg/kg, intraperitoneally) in rats pretreated with chronic morphine for 8 days (n = 8 rats in each group). The data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus values at time 0. #P < 0.05; ###P < 0.001 versus corresponding values in the vehicle or cont peptide group at the same time point. BL, premorphine treatment baseline.

Journal: Anesthesiology

Article Title: α2δ-1–Bound N-Methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

doi: 10.1097/aln.0000000000002648

Figure Lengend Snippet: Fig. 9. Treatment with gabapentin (GBP) or α2δ-1Tat peptide attenuates established hyperalgesia and analgesic tolerance induced by chronic morphine treatment. (A, B) Effect of intraperitoneal injection of vehicle or gabapentin (100 mg/kg) on the baseline mechanical (A) and heat (B) withdrawal thresholds and the acute analgesic effect of morphine (5 mg/kg, intraperitoneally) in rats pretreated with chronic morphine for 8 days (n = 8 rats in each groups). (C, D) Effect of intrathecal injection of α2δ-1Tat peptide (1 μg) or control (cont) peptide (1 μg) on the baseline mechanical (C) and heat (D) withdrawal thresholds and the acute analgesic effect of morphine (5 mg/kg, intraperitoneally) in rats pretreated with chronic morphine for 8 days (n = 8 rats in each group). The data are shown as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 versus values at time 0. #P < 0.05; ###P < 0.001 versus corresponding values in the vehicle or cont peptide group at the same time point. BL, premorphine treatment baseline.

Article Snippet: The blots were probed with a rabbit anti–α2δ-1 antibody (1:500; #ACC-015; Alomone Labs, Israel) or rabbit anti-GAPDH antibody (1:5,000; #14C10; Cell Signaling Technology, USA).

Techniques: Injection, Control